Cargando…
Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases
BACKGROUND: Chronic spontaneous urticaria (CSU) has a detrimental effect on patients’ emotional and physical quality of life. Omalizumab, an anti-immunoglobulin E humanized monoclonal antibody, has been shown to be very effective in the treatment of refractory chronic urticaria patients but may not...
Autores principales: | Subramaniyan, Radhakrishnan, Chopra, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966419/ https://www.ncbi.nlm.nih.gov/pubmed/27512204 http://dx.doi.org/10.4103/0019-5154.185745 |
Ejemplares similares
-
How Effective is Autologous Serum Therapy in Chronic Autoimmune Urticaria
por: Majid, Imran, et al.
Publicado: (2015) -
Subcutaneous Autologous Serum Therapy in Chronic Spontaneous Urticaria
por: Godse, Kiran Vasant, et al.
Publicado: (2017) -
Autologous Serum Therapy in Chronic Urticaria: A Promising Complement to Antihistamines
por: Debbarman, Panchami, et al.
Publicado: (2014) -
Comparison of Efficacy, Safety and Cost-effectiveness of Rupatadine and Olopatadine in Patients of Chronic Spontaneous Urticaria: A Randomized, Double-blind, Comparative, Parallel Group Trial
por: Dakhale, Ganesh N, et al.
Publicado: (2016) -
Therapeutic Plasma Exchange—A New Dawn in the Treatment of Pemphigus Vulgaris
por: Kumar, Rajesh, et al.
Publicado: (2015)